High-Dose Docosahexaenoic Acid in Preterm Newborns and Behavior at Age 5 Years

This randomized clinical trial evaluates behavior at age 5 years among children who received high-dose docosahexaenoic acid as preterm infants.
Source: JAMA Pediatrics - Category: Pediatrics Source Type: research